No Data
What You Can Learn From Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) P/S
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
GuangChuangTong Bridge-B(02190.HK) spent 0.605 million Hong Kong dollars to buy back 0.05 million shares on October 14th.
Glory Health announced on October 14th that on October 14th, it spent 0.605 million Hong Kong dollars to repurchase 0.05 million shares.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business
ZYLOXTB-B: Interim Report 2024
Press Release: Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved ProfitabilityNo Data
No Data
